Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy

Cancer Journal from Scientific American

Volumn 6, Issue SUPPL. 1, 2000, Pages

  Margolin, Kim ^a   Forman, Stephen J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Acute leukemia; Immunotherapy; Interleukin lymphoma

Indexed keywords

INTERLEUKIN 2; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; RECOMBINANT INTERLEUKIN 2;

ARTICLE; CANCER IMMUNOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CROSS RESISTANCE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LYMPHOMA; MYELOMA; PRIORITY JOURNAL; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AUTOTRANSPLANTATION; CLINICAL TRIAL; MIDDLE AGED; FEVER; HYPOTENSION; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; THROMBOCYTOPENIA;

ADULT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-2; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0033849390     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979;300:1068-1073.
2. Weiden PL, Sullivan KM, Flournoy N et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981;304:1529-1533.
3. Fefer A, Sullivan KM, Weiden P et al. Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. Prog Clin Biol Res 1987;244:401-408.
4. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75:555-562.
5. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995;86:2041-2050.
6. Collins RH Jr, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997;15:433-444.
7. Storb R, Yu C, McSweeney P. Mixed chimerism after transplantation of allogeneic hematopoietic cells. In: Thomas E, Blume K, Forman S, eds. Hematopoietic Cell Transplantation (2nd ed). Boston: Blackwell Science, 1999:287-295.
8. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85-86.
9. Fefer A, Cheever MA, Thomas ED et al. Bone marrow transplanttion for refractory acute leukemia in 34 patients with identical twin. Blood 1981;57:421-430.
10. Rosenberg SA. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinanr interleukin-2. Important Adv Oncol 1986;55-91.
11. Agah R, Malloy B, Kerner M et al. Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantation. J Immunol 1989;143:3093-3099.
12. Charak BS, Brynes RK, Groshen S et al. Bone marrow transplanttion with interleukin-2-activated bone marrow followed by interleukin-2 therapy for acute myeloid leukemia in mice. Blood 1990;76:2187-2190.
13. Charak BS, Brynes RK, Katsuda S et al. Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy. Cancer Res 1991;51:2015-2020.
14. Oshimi K, Oshimi Y, Akutsu M et al. Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells. Blood 1986;68:938-948.
15. Fierro MT, Liao XS, Lusso P et al. In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity. Leukemia 1988;2:50-54.
16. Foa R, Carerto P, Fierro MT et al. Inrerleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. Br J Haemato 1990;75:34-40.
17. Foa R, Meloni G, Tosti S et al. Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study. Br J Haematol 1991;77:491-496.
18. Maraninchi D, Blaise D, Viens P et al. High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse. Blood 1991;78:2182-2187.
19. Margolin KA, Wright C, Forman SJ. Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells. Leukemia 1997;11:723-728.
20. Margolin KA, Van Besien K, Wright C et al. Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma. Biol Blood Marrow Transplant 1999;5:36-45.
21. Benyunes MC, Higuchi C, York A et al. Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial. Bone Marrow Transplant 1995;16:283-288.
22. Robinson N, Benyunes MC, Thompson JA et al. Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study. Bone Marrow Transplant 1997;19:435-442.
23. Stein A, Forman SJ et al. Autologous hematopoietic cell transplantation for acute myeloid leukemia. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation (2nd ed). Boston: Blackwell Science, 1999:963-977.
24. Stein AS, O'Donnell MR, Chai A et al. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. J Clin Oncol 1996;14:2206-2216.
25. Fefer A, Robinson N, Benyunes MC et al. Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies. Cancer J Sci Am 1997;3[suppl 1]:S48-S53.
26. Stein A, Slovak M, Sniecinski I et al. Immunotherapy with IL-2 after autologous stem cell transplant for acute myelogenous leukemia in first remission. In: Dicke K, Keating A, eds. Autologous Blood and Marrow Transplantation: Proceedings of the Ninth International Symposium. Arlington, Texas: Garden Jennings, 1999:46-53.